SOUTHERN RESEARCH INSTITUTE - Coronavirus Contracts

Contracts Vendors Agencies Categories States

Coronavirus Contracts

Tracking Federal Purchases to Fight the Coronavirus

Home › All Vendors › Vendor ›

SOUTHERN RESEARCH INSTITUTE

Total Committed Value of Federal Contracts

$7.06M

Total Contracts

Total Actions

Location

Birmingham, AL

Recent Contract Actions

Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.

Description	Category	Agency	Signed	Amount Committed
SOUTHERN RESEARCH INSTITUTE:1109391 [21-003335] - THE PEL IS SEEKING A SERVICE PROVIDER TO ASSAY THE TWO AGENTS DESCRIBED ABOVE FOR ANTI-SARS-COV-2 ACTIVITY. SPECIFICALLY, THE PEL IS SEEKING A PROVIDER OF ASSAYS TO QUANTITATE: (I) VIRAL REPLICATION I	Laboratory Testing	National Institutes of Health	June 03, 2021	$10,750
PCMID: DEVELOPMENT AND USE OF A NON-HUMAN PRIMATE MODEL OF SARS-COV-2 INFECTION	Biomedical R&D	National Institutes of Health	February 16, 2021	$148,678
ASSAY-READY PLATES FOR CYTOPATHIC EFFECT (CPE) AND CYTOTOXICITY ASSAYS FOR SARS-COV-2. MODIFICATION TO EXTEND PERIOD OF PERFORMANCE THROUGH 3/31/2021.	Laboratory Testing	National Institutes of Health	January 07, 2021	$0
ASSAY-READY PLATES FOR CYTOPATHIC EFFECT (CPE) AND CYTOTOXICITY ASSAYS FOR SARS-COV-2	Laboratory Testing	National Institutes of Health	December 09, 2020	$27,000
PCMID: DEVELOPMENT AND USE OF A NON-HUMAN PRIMATE MODEL OF SARS-COV-2 INFECTION	Biomedical R&D	National Institutes of Health	November 17, 2020	$0
COVID-19 CONTRACT ACTION. DETERMINATION OF OPTIMAL VIRUS DILUTION AND TIME COURSE TO MEASURE SARS-COV-2 VIRAL LOAD BY ALPHALISA. POP: 09/16/2020 TO 11/15/2020.	Chemical/Biological Special Studies/Analysis	National Institutes of Health	September 16, 2020	$20,000
TESTING OF MAP30-TAT X DEXAMETHASONE SAMPLES FOR INHIBITION OF COVID-19 BINDING TO ACE2 RECEPTOR IN CELL CULTURE NEEDED FOR STUDIES OF THIS VIRUS.	Laboratory Testing	National Institutes of Health	July 31, 2020	$15,000
PCMID: DEVELOPMENT AND USE OF A NON-HUMAN PRIMATE MODEL OF SARS-COV-2 INFECTION	Biomedical R&D	National Institutes of Health	July 15, 2020	$0
COVID-19 COMPOUND TESTING AND CYTOTOXICITY SCREEN IN THE SARS-COV-2 CPE ASSAY	Laboratory Testing	National Institutes of Health	July 10, 2020	$37,000
COVID-19 COMPOUND TESTING AND CYTOTOXICITY SCREEN IN THE SARS-COV-2 CPE ASSAY (2 ROUNDS)	Laboratory Testing	National Institutes of Health	May 26, 2020	$74,000
COMPOUND TESTING AND CYTOTOXICITY SCREEN IN THE SARS-COV-2 CPE ASSAY	Laboratory Testing	National Institutes of Health	May 05, 2020	$37,000
COVID-19 COMPOUND TESTING AND CYTOTOXICITY SCREEN IN THE SARS-COV-2 CPE ASSAY	Laboratory Testing	National Institutes of Health	April 24, 2020	$42,000
PCMID: DEVELOPMENT AND USE OF A NON-HUMAN PRIMATE MODEL OF SARS-COV-2 INFECTION	Biomedical R&D	National Institutes of Health	April 23, 2020	$0
DEVELOPMENT OF ANIMAL MODELS FOR EVALUATION OF MEDICAL COUNTERMEASURES FOR SARS-COV-2	Biomedical Advanced Development R&D	Office of Assistant Secretary for Preparedness and Response - HHS	March 31, 2020	$4,745,435
DEVELOPMENT OF ANIMAL MODELS FOR EVALUATION OF MEDICAL COUNTERMEASURES FOR SARS-COV-2	Biomedical Advanced Development R&D	Office of Assistant Secretary for Preparedness and Response - HHS	March 30, 2020	$960,088
NCATS COMPOUNDS DOSE RESPONSE TESTING FOR COVID-19 PROJECT.	Laboratory Testing	National Institutes of Health	March 27, 2020	$47,000
PCMID: DEVELOPMENT AND USE OF A NON-HUMAN PRIMATE MODEL OF SARS-COV-2 INFECTION	Biomedical R&D	National Institutes of Health	March 27, 2020	$896,460

See this vendor on usaspending.gov ›

About this data

This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.